Jane Street
COYA icon

Jane Street’s Coya Therapeutics COYA Stock Holding History

Jane Street’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$250K Buy
+63,400
New +$296K ﹤0.01% 9631

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Jane Street's COYA Position: Q1 2026 in Review

Jane Street reduced its Coya Therapeutics (COYA) stake by 61% in Q1 2026, selling an estimated $95.8K and leaving 13,340 shares worth $52.6K. The position accounts for ﹤0.01% of the portfolio, ranked #10954.

Jane Street first reported a position in COYA in Q1 2024 and has held it in 6 quarters since. The position peaked at $199K in Q1 2024. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • Jane Street held 13,340 shares of Coya Therapeutics worth $52.6K as of Q1 2026.
  • Jane Street sold 20,484 Coya Therapeutics shares in Q1 2026, an estimated $95.8K.
  • Coya Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10954 holding.
  • Jane Street first reported a position in Coya Therapeutics in Q1 2024 and has held it in 6 quarters since.
  • Jane Street's Coya Therapeutics position peaked at $199K in Q1 2024.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.